Condition
Ovariectomy
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
66.7%-20% vs avg
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
66.7%
-19.8% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
67% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed2
Unknown2
Terminated1
Trial Success Rate
66.7%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03294343Not ApplicableUnknown
Risk-Reducing Surgeries for Hereditary Ovarian Cancer
NCT00551785TerminatedPrimary
Surveillance Study of Women Taking Intrinsa®
NCT00494208Not ApplicableCompleted
TDSM- Testosterone Dose Response in Surgically Menopausal Women
NCT00373464Phase 3Completed
Etoricoxib for Routine Post-operative Pain Prophylaxis in Laparoscopic Surgery
NCT00173550Unknown
Perception and Attitude Toward Estrogen Therapy Among Surgically Menopausal Women
Showing all 5 trials